What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions

CMS didn’t wait for Pres­i­dent-elect Don­ald Trump to take of­fice be­fore is­su­ing its sec­ond list of drugs to be ne­go­ti­at­ed un­der the In­fla­tion Re­duc­tion Act …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER